---
title: "Cobenfy (xanomeline and trospium chloride) in schizophrenia: Storage and supply questions"
description: "Storage and supply questions on Cobenfy (xanomeline and trospium chloride) in schizophrenia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied and Storage. Questions: What strengths does COBENFY come in? How should COBENFY be stored? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/cobenfy--schizophrenia/storage-and-supply"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Cobenfy (xanomeline and trospium chloride) in schizophrenia: Storage and supply questions

Manufacturer: Bristol-Myers Squibb Company  
Prescribing information: [Cobenfy](https://packageinserts.bms.com/pi/pi_cobenfy.pdf)

## How supplied

<a id="cobenfy-strengths-storage"></a>

### What strengths does COBENFY come in?

> “COBENFY (xanomeline and trospium chloride) is available in 50mg/20mg, 100mg/20mg, and 125mg/30mg capsules.”

Source: [COBENFY: The Safety of COBENFY™ (xanomeline and trospium chloride) | For HCPs, captured 2026-11-08](https://www.cobenfyhcp.com/safety#:~:text=COBENFY%20%28xanomeline%20and%20trospium%20chloride%29,50mg%2F20mg%2C%20100mg%2F20mg%2C%20and%20125mg%2F30mg%20capsules.)

## Storage

<a id="cobenfy-storage"></a>

### How should COBENFY be stored?

> “Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) 
> [ see USP Controlled Room Temperature].”

Source: [COBENFY: Prescribing information, page 7, captured 2026-11-13](https://packageinserts.bms.com/pi/pi_cobenfy.pdf#page=7)

## Related pages
- [Medical information: Cobenfy (xanomeline and trospium chloride): Schizophrenia](https://www.evicenter.com/medical-information/cobenfy--schizophrenia)
- [Indication](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/cobenfy--schizophrenia/access-and-coverage)
